Inventor · disambiguated record
Christopher Self
Also filed as: SELF CHRISTOPHER · SELF CHRISTOPHER R · SELF CHRISTOPHER RAYMOND
26 granted patents·7 pending applications·516 citations·filing 1986–2022
97Inventor score
Files withPRAECIS PHARM INC14HOFFMANN LA ROCHE3IMMUNE CONTROL INC3OLSON GARY LEE2PROVID PHARMACEUTICALS INC2
Top patents by PatentIndex Score
33 records- 0197US6548477B1Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2000·Granted Apr 15, 2003·142 cites·52 claims
- 0296US7268111B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2005·Granted Sep 11, 2007·64 cites·44 claims
- 0395US7084108B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2001·Granted Aug 1, 2006·72 cites·27 claims
- 0492US7037890B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2001·Granted May 2, 2006·42 cites·59 claims
- 0591US7348307B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Granted Mar 25, 2008·9 cites·71 claims
- 0690US9592221B2Antibacterial agents: aryl myxopyronin derivativesUNIV RUTGERS·Filed 2016·Granted Mar 14, 2017·7 cites·19 claims
- 0789US9315495B2Antibacterial agents: aryl myxopyronin derivativesUNIV RUTGERS·Filed 2013·Granted Apr 19, 2016·8 cites·10 claims
- 0889US7432342B2Kinase anchor protein muteins, peptides thereof and related documentsSEQUENOM INC·Filed 2003·Granted Oct 7, 2008·40 cites·17 claims
- 0988US6919307B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2002·Granted Jul 19, 2005·26 cites·53 claims
- 1087US7947645B2APO E analogs and methods for their useCOGNOSCI INC·Filed 2005·Granted May 24, 2011·13 cites·37 claims
- 1186US8598312B2Inhibitors of antigen presentation by MHC class II moleculesOLSON GARY LEE·Filed 2012·Granted Dec 3, 2013·8 cites·6 claims
- 1286US8222215B2Methods for the use of inhibitors of antigen presentation by MHC class II moleculesOLSON GARY LEE·Filed 2008·Granted Jul 17, 2012·9 cites·26 claims
- 1384US7105482B2Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2003·Granted Sep 12, 2006·14 cites·43 claims
- 1484US6610658B1Modulators of μ-amyloid peptide aggregationPRAECIS PHARM INC·Filed 2000·Granted Aug 26, 2003·15 cites·5 claims
- 1582US7405194B2Therapeutic agents and methods of use thereof for the treatment of melanomaPRAECIS PHARM INC·Filed 2006·Granted Jul 29, 2008·4 cites·71 claims
- 1679US7157420B2Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2004·Granted Jan 2, 2007·10 cites·46 claims
- 1776US7981885B2Compositions for treatment of diseases related to activated lymphocytesIMMUNE CONTROL INC·Filed 2007·Granted Jul 19, 2011·3 cites·2 claims
- 1875US7439231B2Inhibitors of antigen presentation by MHC class II molecules and methods of use thereofPROVID PHARMACEUTICALS INC·Filed 2004·Granted Oct 21, 2008·10 cites·10 claims
- 1972US7923445B2Methods for treatment of diseases related to activated lymphocytesIMMUNE CONTROL INC·Filed 2007·Granted Apr 12, 2011·2 cites·11 claims
- 2072US4774253AOxazole and isoxazole derivatives having anti-arthritic activityHOFFMANN LA ROCHE·Filed 1986·Granted Sep 27, 1988·11 cites·18 claims
- 2161US2009156624A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2008·Application pending·0 cites
- 2260US7803774B2Modulators of β-amyloid peptide aggregationPRAECIS PHARM INC·Filed 2004·Granted Sep 28, 2010·1 cites·8 claims
- 2359US8071552B2Peptides and peptidomimetics binding to CD23MOSSALAYI MOHAMMAD DJAVAD·Filed 2005·Granted Dec 6, 2011·2 cites·5 claims
- 2457US2007117758A1Therapeutic agents and methods of use thereof for the modulation of angiogenesisPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 2556US2024158439A1Inhibitors of antigen presentation by mhc class ii hla-drb1*15:01 molecules with enhanced metabolic stabilityPROVID PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2656US2009155846A1Kinase anchor protein muteins, peptides thereof and related methodsSEQUENOM INC·Filed 2008·Application pending·0 cites
- 2751US2011217324A1Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereofOLSON GARY L·Filed 2008·Application pending·0 cites
- 2847US2009275557A1Novel Composition for Treatment of Diseases Related to Activated LymphocytesIMMUNE CONTROL INC·Filed 2009·Application pending·0 cites
- 2946US2007161570A1Methionine aminopeptidase-2 inhibitors and methods of use thereofPRAECIS PHARM INC·Filed 2006·Application pending·0 cites
- 3039US8765802B2Kinase inhibitors, compositions thereof, and methods of use therewithSHOEMAKER ROBERT·Filed 2008·Granted Jul 1, 2014·0 cites·3 claims
- 3139US5994569ADihomo-seco-cholestanesHOFFMANN LA ROCHE·Filed 1998·Granted Nov 30, 1999·3 cites·28 claims
- 3238US9278089B2Method of treating HCV infection with a small molecule CHK2 inhibitorUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2012·Granted Mar 8, 2016·0 cites·23 claims
- 3334US5114960ASubstituted isoxazole derivativesHOFFMANN LA ROCHE·Filed 1990·Granted May 19, 1992·1 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Self files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →